These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparative flow cytometric analysis of proliferating cell nuclear antigen (PCNA) antibodies in human solid neoplasms. Teague K, el-Naggar A. Cytometry; 1994 Jan 01; 15(1):21-7. PubMed ID: 7909288 [Abstract] [Full Text] [Related]
3. Direct comparison of bromodeoxyuridine and Ki-67 labelling indices in human tumours. Wilson GD, Saunders MI, Dische S, Daley FM, Robinson BM, Martindale CA, Joiner B, Richman PI. Cell Prolif; 1996 Mar 01; 29(3):141-52. PubMed ID: 8652743 [Abstract] [Full Text] [Related]
4. Three parameter flow cytometric analysis for simultaneous detection of cytokeratin, proliferation associated antigens and DNA content. Schutte B, Tinnemans MM, Pijpers GF, Lenders MH, Ramaekers FC. Cytometry; 1995 Oct 01; 21(2):177-86. PubMed ID: 8582238 [Abstract] [Full Text] [Related]
5. Measurement of the proliferative activity of three different sublines of the Dunning rat prostate tumor R3327. Lohr F, Wenz F, Flentje M, Peschke P, Hahn EW. Strahlenther Onkol; 1993 Jul 01; 169(7):438-45. PubMed ID: 8342118 [Abstract] [Full Text] [Related]
6. Flow cytometric analysis of the expression of PCNA during the cell cycle in HeLa cells and effects of the inhibition of DNA synthesis on it. Sasaki K, Kurose A, Ishida Y. Cytometry; 1993 Nov 01; 14(8):876-82. PubMed ID: 7904555 [Abstract] [Full Text] [Related]
7. Pan cycle expression of proliferating cell nuclear antigen in human colorectal cancer and its proliferative correlations. Sawtell RM, Rew DA, Stradling RN, Wilson GD. Cytometry; 1995 Sep 15; 22(3):190-9. PubMed ID: 8556950 [Abstract] [Full Text] [Related]
8. DNA analysis of head and neck squamous cell carcinoma by flow cytometry. Lampe HB. Laryngoscope; 1993 Jun 15; 103(6):637-44. PubMed ID: 8099190 [Abstract] [Full Text] [Related]
9. Lack of correlation between flow cytometric and immunohistologic proliferation measurements of tumors. Linden MD, el-Naggar AK, Nathanson SD, Jacobson G, Zarbo RJ. Mod Pathol; 1996 Jun 15; 9(6):682-9. PubMed ID: 8782208 [Abstract] [Full Text] [Related]
10. Immunoreactivity of proliferating cell nuclear antigen compared with bromodeoxyuridine incorporation in normal and neoplastic rat tissue. Wijsman JH, Van Dierendonck JH, Keijzer R, van de Velde CJ, Cornelisse CJ. J Pathol; 1992 Sep 15; 168(1):75-83. PubMed ID: 1360499 [Abstract] [Full Text] [Related]
11. Predictive value of the flow cytometric PCNA assay (proliferating cell nuclear antigen) in head and neck tumors after accelerated-hyperfractionated radiochemotherapy. Wenz F, Lohr F, Flentje M, Rudat V, Dietz A, Wannenmacher M. Int J Radiat Oncol Biol Phys; 1997 Mar 01; 37(4):771-6. PubMed ID: 9128950 [Abstract] [Full Text] [Related]
12. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen. Chae YS, Flotte T, Hsu DW, Preffer F, Hedley-Whyte ET. Gen Diagn Pathol; 1996 Oct 01; 142(2):89-95. PubMed ID: 8950573 [Abstract] [Full Text] [Related]
13. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA). Crucitti A, Masetti R, Breccia C, Coppola R, Magistrelli P, Nuzzo G, Maggiano N, Picciocchi A. Hepatogastroenterology; 1999 Oct 01; 46(26):1187-91. PubMed ID: 10370689 [Abstract] [Full Text] [Related]
14. Flow cytometric quantification of the proliferation-associated nuclear antigen p105 and DNA content in advanced head & neck cancers: results of RTOG 91-08. Fu KK, Hammond E, Pajak TF, Clery M, Doggett RL, Byhardt RW, McDonald S, Cooper JS. Int J Radiat Oncol Biol Phys; 1994 Jul 01; 29(4):661-71. PubMed ID: 7913703 [Abstract] [Full Text] [Related]
15. A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma. Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fraction. Nordström B, Strang P, Bergström R, Nilsson S, Tribukait B. Cancer; 1996 Nov 01; 78(9):1942-51. PubMed ID: 8909315 [Abstract] [Full Text] [Related]
16. S-phase arrest of nutrient deprived lung cancer cells. Tinnemans MM, Lenders MH, ten Velde GP, Blijham GH, Ramaekers FC, Schutte B. Cytometry; 1995 Apr 01; 19(4):326-33. PubMed ID: 7796697 [Abstract] [Full Text] [Related]
17. [Flow cytometric techniques for measurement of proliferating cell nuclear antigen (PCNA)]. Ichikawa A, Shimamura K, Koyama Y. Nihon Rinsho; 1992 Oct 01; 50(10):2343-8. PubMed ID: 1360029 [Abstract] [Full Text] [Related]
18. Measurement of proliferative index in squamous cell carcinoma by flow cytometry. Ferguson PJ, Garland A, Lampe HB. J Otolaryngol; 1992 Oct 01; 21(5):331-8. PubMed ID: 1361586 [Abstract] [Full Text] [Related]
19. Comparative flow cytometric analysis of DNA-bound PCNA and DNA content as estimators of S-phase cells in cell cultures. Bustamante AS, Guervós MA, de los Toyos JR, Dolbeare F, Sampedro A. Anal Cell Pathol; 1996 Jul 01; 11(2):127-36. PubMed ID: 8844110 [Abstract] [Full Text] [Related]
20. Expression of proliferation-associated antigens (PCNA, p120, p145) during the reentry of G0 cells into the cell cycle. Bolton WE, Freeman JW, Mikulka WR, Healy CG, Schmittling RJ, Kenyon NS. Cytometry; 1994 Sep 01; 17(1):66-74. PubMed ID: 8001459 [Abstract] [Full Text] [Related] Page: [Next] [New Search]